Narayana Nethralaya’s Revolutionary Tear-based Diagnostic Kit
Researchers at Narayana Nethralaya’s GROW laboratory are developing a tear-based diagnostic kit that will help predict, diagnose, and monitor the progression of several eye diseases and disorders such as Dry eye, Keratoconus, Uveitis, Myopia, Age-Related Macular Degeneration, and Diabetic Retinopathy. Dr Rohit Shetty, Vice-chairman, Narayana Nethralaya, hopes to extend this human tear-based fluid analysis for Parkinson’s, Alzheimer’s and Cancer in the near future. Human tears are an easily accessible body fluid when compared to serum or plasma and offer a less invasive method of collecting samples from patients. According to Dr Arkasubhra Ghosh, director of GROW Lab, this biomarker kit will allow your doctor to tell the status of your health with just your teardrop and will be available in India by the end of 2023.